Ignite Creation Date:
2025-12-25 @ 1:33 AM
Ignite Modification Date:
2025-12-27 @ 10:13 PM
Study NCT ID:
NCT00716794
Status:
COMPLETED
Last Update Posted:
2011-03-09
First Post:
2008-07-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I/II Study of HE3235 in Patients With Prostate Cancer
Sponsor:
Harbor Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
HE3235-0201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Nanette Onizuka-Handa/Sr. Vice President, Regulatory Affairs and Quality
Old Organization:
Harbor BioSciences, Inc.